Key Record Dates
ClinicalTrials.gov Identifier: | NCT03319849 |
---|---|
Brief Title: | A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 |
First Submitted : | October 3, 2017 |
First Submitted that Met QC Criteria : | October 19, 2017 |
First Posted : | October 24, 2017 |
Last Update Submitted that Met QC Criteria : | September 21, 2020 |
Last Update Posted : | September 22, 2020 |